National Current Ratio from 2010 to 2024

NHI Stock  USD 77.00  0.71  0.91%   
National Health's Current Ratio is increasing with slightly volatile movements from year to year. Current Ratio is estimated to finish at 61.57 this year. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
58.63388251
Current Value
61.57
Quarterly Volatility
19.67359321
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check National Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.5 M, Interest Expense of 58.3 M or Total Revenue of 170.8 M, as well as many indicators such as Price To Sales Ratio of 7.26, Dividend Yield of 0.0868 or PTB Ratio of 1.84. National financial statements analysis is a perfect complement when working with National Health Valuation or Volatility modules.
  
Check out the analysis of National Health Correlation against competitors.

Latest National Health's Current Ratio Growth Pattern

Below is the plot of the Current Ratio of National Health Investors over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. National Health's Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National Health's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2.78 X10 Years Trend
Slightly volatile
   Current Ratio   
       Timeline  

National Current Ratio Regression Statistics

Arithmetic Mean12.44
Geometric Mean6.08
Coefficient Of Variation158.12
Mean Deviation13.27
Median4.99
Standard Deviation19.67
Sample Variance387.05
Range60.2257
R-Value0.57
Mean Square Error282.99
R-Squared0.32
Significance0.03
Slope2.49
Total Sum of Squares5,419

National Current Ratio History

2024 61.57
2023 58.63
2022 5.43
2021 7.2
2019 4.99
2018 5.37
2017 4.34

About National Health Financial Statements

Investors use fundamental indicators, such as National Health's Current Ratio, to determine how well the company is positioned to perform in the future. Although National Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Ratio 58.63  61.57 

Currently Active Assets on Macroaxis

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:
Check out the analysis of National Health Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.14)
Dividend Share
3.6
Earnings Share
2.91
Revenue Per Share
7.598
Quarterly Revenue Growth
(0.12)
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.